GOOD MANUFACTURING PRACTICE GUIDE FOR MEDICINAL GASES

AIGA 023/05

Asia Industrial Gases Association

3 HarbourFront Place, #09-04 HarbourFront Tower 2 Singapore 099254 Tel : +65 62760160 Fax : +65 62749379

Internet : http://www.asiaiga.org

© Reproduced with permission from European Industrial Gases Association. All rights reserved.

ASIA INDUSTRIAL GASES ASSOCIATION 3 HarbourFront Place, #09-04 HarbourFront Tower 2 Singapore 099254

Tel: +65 62760160 Fax: +65 62749379

Internet: http://www.asiaiga.org

AIGA 023/05

GOOD MANUFACTURING

PRACTICE GUIDE FOR MEDICINAL GASES

KEYWORDS

• INSPECTION • LABELLING • LEGISLATION • MEDICAL • STORAGE • TRAINING • CLEANING • GMP • QUALIFIED PERSON • FINISHED PRODUCT • PATIENT SAFETY • MEDICINAL GAS • VALIDATION • BATCH

Disclaimer

All technical publications of AIGA or under AIGA’s name, including Codes of practice, Safety procedures and any other technical information contained in such publications were obtained from sources believed to be reliable and are based on technical information and experience currently available from members of AIGA and others at the date of their issuance. While AIGA recommends reference to or use of its publications by its members, such reference to or use of AIGA’s publications by its members or third parties are purely voluntary and not binding. Therefore, AIGA or its members make no guarantee of the results and assume no liability or responsibility in connection with the reference to or use of information or suggestions contained in AIGA’s publications.

AIGA has no control whatsoever as regards, performance or non performance, misinterpretation, proper or improper use of any information or suggestions contained in AIGA’s publications by any person or entity (including AIGA members) and AIGA expressly disclaims any liability in connection thereto.

AIGA’s publications are subject to periodic review and users are cautioned to obtain the latest edition.

AIGA 023/05

Acknowledgement

This document is adopted from the European Industrial Gases Association, IGC 99/03 E : ‘Good Manufacturing Practice Guide for Medicinal Gases’. Acknowledgement and thanks are hereby given to EIGA for permission granted for the use of their document.

AIGA 023/05

Table of Contents

1 Introduction ......................................................................................................................................1

2 Scope and Purpose .........................................................................................................................1 2.1 Scope ....................................................................................................................................1 2.2 Purpose.................................................................................................................................2

3 Definitions ........................................................................................................................................2

4 Quality Management (EC GMP Chapter 1) ....................................................................................3 4.1 Principle ................................................................................................................................3 4.2 Quality Assurance (QA) ........................................................................................................4 4.3 Good Manufacturing Practice (GMP) for Medicinal Gases...................................................5 4.4 Quality Control (QC) .............................................................................................................5

5 Personnel (EC GMP Chapter 2) .....................................................................................................6 5.1 Principle ................................................................................................................................6 5.2 General .................................................................................................................................6

5.2.1 Personnel requirements ....................................................................................................6 5.2.2 Organisation Chart ............................................................................................................6

5.3 Key Personnel.......................................................................................................................7 5.3.1 Responsibilities..................................................................................................................7 5.3.2 Independence....................................................................................................................7 5.3.3 Person Responsible for Production...................................................................................7 5.3.4 Person Responsible for Quality Control ............................................................................7 5.3.5 Joint Responsibilities.........................................................................................................8 5.3.6 The Qualified Person.........................................................................................................8

5.4 Training .................................................................................................................................8 5.4.1 Hazard Areas.....................................................................................................................9 5.4.2 Visitors...............................................................................................................................9 5.4.3 Quality Assurance Training ...............................................................................................9

5.5 Protective Clothing................................................................................................................9 5.6 Personal Hygiene..................................................................................................................9

6 Premises and Equipment (EC GMP Chapter 3) .............................................................................9 6.1 Principle ................................................................................................................................9 6.2 Premises .............................................................................................................................10

6.2.1 Maintenance....................................................................................................................10 6.2.2 Unauthorised Entry..........................................................................................................10

6.3 Manufacturing Areas - Production ......................................................................................10 6.3.1 Location ...........................................................................................................................10 6.3.2 Storage Areas..................................................................................................................10

6.4 Manufacturing Areas - Cylinder Filling................................................................................10 6.4.1 Layout..............................................................................................................................10 6.4.2 Segregated Areas ...........................................................................................................12 6.4.3 Inspection and Testing Areas..........................................................................................12 6.4.4 Lighting ............................................................................................................................12 6.4.5 In-process Controls .........................................................................................................12

6.5 Storage Areas - Cylinder Filling ..........................................................................................12 6.5.1 Layout..............................................................................................................................12 6.5.2 Storage Area Protection ..................................................................................................12 6.5.3 Stock Rotation .................................................................................................................13 6.5.4 Reject Cylinder Storage ..................................................................................................13 6.5.5 Label Storage ..................................................................................................................13 6.5.6 Storage Protection...........................................................................................................13

6.6 Quality Control Areas..........................................................................................................13 6.6.1 Environmentally Controlled Areas...................................................................................13 6.6.2 Area Segregation ............................................................................................................13

6.7 Ancillary Areas ....................................................................................................................13

AIGA 023/05

6.7.1 Rest Areas.......................................................................................................................13 6.7.2 Toilet Areas .....................................................................................................................13 6.7.3 Maintenance Areas .........................................................................................................14

6.8 Equipment ...........................................................................................................................14 6.8.1 Maintenance and Cleaning..............................................................................................14 6.8.2 Material Selection............................................................................................................14 6.8.3 Calibration .......................................................................................................................14 6.8.4 Labelling ..........................................................................................................................14 6.8.5 Defective Equipment .......................................................................................................14

6.9 Equipment - Bulk Production ..............................................................................................15 6.9.1 Plant Segregation............................................................................................................15 6.9.2 Air Filtration .....................................................................................................................15 6.9.3 Controlled Conditions ......................................................................................................15 6.9.4 Equipment - Medicinal Cylinder Filling ............................................................................15 6.9.5 Cylinder Filling Manifolds ................................................................................................15 6.9.6 Medicinal Cylinders .........................................................................................................15 6.9.7 Shared Filling Systems....................................................................................................15 6.9.8 Pipeline Interconnections ................................................................................................16 6.9.9 Non-automated Filling Systems ......................................................................................16

6.10 Equipment - Bulk Storage and Transport ...........................................................................16 6.10.1 Storage Tanks .................................................................................................................16 6.10.2 Common Storage Tanks .................................................................................................16 6.10.3 Common Delivery Vehicles .............................................................................................16

7 Documentation (EC GMP Chapter 4) ...........................................................................................17 7.1 Principles.............................................................................................................................17 7.2 General ...............................................................................................................................17

7.2.1 Starting Materials ............................................................................................................17 7.2.2 Work Instructions.............................................................................................................17 7.2.3 Standard Operating Procedures......................................................................................17 7.2.4 Batch Records.................................................................................................................17 7.2.5 Document Control ...........................................................................................................17 7.2.6 Document Approval.........................................................................................................18 7.2.7 Document Design............................................................................................................18 7.2.8 Document Review ...........................................................................................................18 7.2.9 Data Entry........................................................................................................................18 7.2.10 Alterations........................................................................................................................18 7.2.11 Record Retention ............................................................................................................18 7.2.12 Electronic Records ..........................................................................................................18 7.2.13 Continuous Processes ....................................................................................................19

7.3 Specifications ......................................................................................................................19 7.3.1 General............................................................................................................................19 7.3.2 Starting and Packaging Materials....................................................................................19 7.3.3 Bulk Medicinal Gases......................................................................................................19 7.3.4 Finished Medicinal Gas ...................................................................................................20 7.3.5 Medicinal Gas Cylinders..................................................................................................20 7.3.6 Medicinal Gas Cylinder Valves........................................................................................20 7.3.7 Medicinal Gas Cylinder Labels and Patient Information Leaflets....................................20 7.3.8 Medicinal Gas Storage Tanks .........................................................................................21

7.4 Procedures and Work Instructions......................................................................................21 7.4.1 General............................................................................................................................21 7.4.2 Bulk Medicinal Gases Production Procedures ................................................................21 7.4.3 Bulk Medicinal Gases Production Work Instructions.......................................................21 7.4.4 Medicinal Cylinders Filling Procedures ...........................................................................22 7.4.5 Medicinal Cylinders Filling Work Instructions..................................................................22 7.4.6 Bulk Medicinal Gas Supply Procedures ..........................................................................22 7.4.7 Bulk Medicinal Gas Supply Work Instructions.................................................................23

7.5 Batch records ......................................................................................................................23 7.5.1 Bulk Manufacture Batch Definition ..................................................................................23 7.5.2 Continuous Production Batch Records ...........................................................................23 7.5.3 Production Batch Data ....................................................................................................23

AIGA 023/05

7.5.4 Cylinder Filling Bulk Gas Supply .....................................................................................24 7.5.5 Cylinder Filling Batch Record ..........................................................................................24 7.5.6 Bulk Medicinal Gas Batch Records.................................................................................25

7.6 Other Records.....................................................................................................................25 7.6.1 Trend Analysis.................................................................................................................25 7.6.2 Sampling Procedures ......................................................................................................25 7.6.3 In-process Controls .........................................................................................................26 7.6.4 Release and Rejection Procedures.................................................................................26 7.6.5 Batch Distribution Records..............................................................................................26 7.6.6 Records ...........................................................................................................................26

8 Production (EC GMP Chapter 5) ..................................................................................................26 8.1 Principles.............................................................................................................................26 8.2 General ...............................................................................................................................27

8.2.1 Production Personnel ......................................................................................................27 8.2.2 Product Identification.......................................................................................................27 8.2.3 Validated Processes........................................................................................................27 8.2.4 Control of Starting Materials............................................................................................27 8.2.5 Plant Yield .......................................................................................................................27 8.2.6 Plant labelling ..................................................................................................................27 8.2.7 Deviations from Procedures ............................................................................................27 8.2.8 Retained Samples ...........................................................................................................28 8.2.9 Cross Contamination.......................................................................................................28

8.3 Validation ............................................................................................................................28 8.3.1 General............................................................................................................................28 8.3.2 Validation Studies............................................................................................................28 8.3.3 Process Validation...........................................................................................................28 8.3.4 Computer Validation........................................................................................................28 8.3.5 Change Control ...............................................................................................................28 8.3.6 Validation Review............................................................................................................28

8.4 Starting Materials ................................................................................................................29 8.4.1 General............................................................................................................................29 8.4.2 Suppliers..........................................................................................................................29 8.4.3 Bulk Gas Deliveries .........................................................................................................29 8.4.4 Starting Material Release ................................................................................................29

8.5 Production - Bulk Medicinal Gases.....................................................................................29 8.5.1 Bulk Medicinal Gases Classification ...............................................................................29 8.5.2 Process Flow Charts .......................................................................................................29 8.5.3 Plant Design ....................................................................................................................30 8.5.4 In-process control ............................................................................................................30 8.5.5 Transfer operations .........................................................................................................30 8.5.6 Batch Control...................................................................................................................30 8.5.7 Traceability ......................................................................................................................30

8.6 Production - Medicinal Gas Cylinder Filling ........................................................................30 8.6.1 Medicinal Gas Filling Manifolds.......................................................................................30 8.6.2 Traceability ......................................................................................................................30 8.6.3 Batch Control...................................................................................................................30 8.6.4 Medicinal Cylinder Valves ...............................................................................................31 8.6.5 Cylinder Testing...............................................................................................................31 8.6.6 Pre-fill Checks .................................................................................................................31 8.6.7 Cylinder Preparation........................................................................................................31 8.6.8 Post-fill Checks................................................................................................................32 8.6.9 Gas Mixing.......................................................................................................................32 8.6.10 Leak Checking.................................................................................................................32 8.6.11 Medicinal Gas Cylinder Labelling....................................................................................32 8.6.12 In-process Controls .........................................................................................................32 8.6.13 Tamper Evident Seals .....................................................................................................32

8.7 Equipment Cleaning............................................................................................................32 8.7.1 Pipework Cleaning ..........................................................................................................32 8.7.2 Change of Service...........................................................................................................33

8.8 Packaging Materials - Medicinal Gas Cylinder Filling.........................................................33

AIGA 023/05

8.8.1 General............................................................................................................................33 8.8.2 Label and Leaflet Supplier...............................................................................................33 8.8.3 Label and leaflet storage .................................................................................................33 8.8.4 Label Design....................................................................................................................33 8.8.5 Obsolete Labels...............................................................................................................33 8.8.6 Cylinder labelling .............................................................................................................33 8.8.7 Label Quality....................................................................................................................33 8.8.8 Unused Labels.................................................................................................................34

8.9 Finished Products - Cylinders .............................................................................................34 8.9.1 General............................................................................................................................34 8.9.2 Quarantine Area ..............................................................................................................34 8.9.3 Released Cylinders .........................................................................................................34

8.10 Rejected Products...............................................................................................................34 8.10.1 General............................................................................................................................34 8.10.2 Incident Cylinders............................................................................................................34

9 Quality Control (EC GMP Chapter 6)............................................................................................34 9.1 Principles.............................................................................................................................34 9.2 General ...............................................................................................................................35

9.2.1 Quality Control Responsibilities.......................................................................................35 9.2.2 Quality Control Resource ................................................................................................35 9.2.3 Product Release..............................................................................................................35 9.2.4 Quality Control Requirements .........................................................................................35 9.2.5 Quality Control Documentation .......................................................................................36

9.3 Sampling .............................................................................................................................36 9.3.1 General............................................................................................................................36 9.3.2 Retained Samples ...........................................................................................................36

9.4 Bulk Production...................................................................................................................36 9.4.1 Principal Requirements ...................................................................................................36 9.4.2 Monitoring........................................................................................................................37 9.4.3 In-process Tests..............................................................................................................37 9.4.4 Cooling Water..................................................................................................................37 9.4.5 Bulk Gas Sampling..........................................................................................................37

9.5 Cylinder Filling.....................................................................................................................37 9.5.1 Principal Requirements ...................................................................................................37 9.5.2 Starting Materials ............................................................................................................38 9.5.3 Manifold Filled Cylinders .................................................................................................38 9.5.4 Singularly Filled Cylinders ...............................................................................................38 9.5.5 Medicinal Gas Mixtures ...................................................................................................38 9.5.6 Correct Mixing .................................................................................................................38 9.5.7 Dynamic Mixing ...............................................................................................................39

9.6 Testing ................................................................................................................................39 9.6.1 Test Records ...................................................................................................................39 9.6.2 Moisture Testing..............................................................................................................39 9.6.3 Cryogenic Containers Filled at the Production Site.........................................................39 9.6.4 Cryogenic Container not Filled at the Production Site ....................................................39 9.6.5 Leak Testing....................................................................................................................40 9.6.6 Water Quality...................................................................................................................40 9.6.7 Calibration Gases............................................................................................................40

10 Contract Management and Analysis (EC GMP Chapter 7).......................................................40 10.1.1 Principle...........................................................................................................................40

10.2 General ...............................................................................................................................40 10.2.1 Written Contracts.............................................................................................................40 10.2.2 Compliance with Marketing Authorisation .......................................................................40

10.3 Contract Giver .....................................................................................................................40 10.3.1 Responsibilities................................................................................................................41 10.3.2 Product Specifications.....................................................................................................41 10.3.3 Product Release..............................................................................................................41

10.4 Contract Acceptor ...............................................................................................................41 10.4.1 Contract Acceptor Qualifications.....................................................................................41

AIGA 023/05

10.4.2 Responsibilities................................................................................................................41 10.4.3 Sub-contract Activities.....................................................................................................41

10.5 The Contract .......................................................................................................................42 10.5.1 General............................................................................................................................42 10.5.2 Release for Sale..............................................................................................................42 10.5.3 Specified Responsibilities................................................................................................42 10.5.4 Records ...........................................................................................................................42 10.5.5 Auditing............................................................................................................................42 10.5.6 Good Laboratory Practice ...............................................................................................43

11 Complaint and Product Recall (EC GMP Chapter 8) ................................................................43 11.1 Principle ..............................................................................................................................43 11.2 Complaints ..........................................................................................................................43

11.2.1 Responsibilities................................................................................................................43 11.2.2 Written procedures ..........................................................................................................43 11.2.3 Records ...........................................................................................................................43 11.2.4 Product Review ...............................................................................................................43 11.2.5 Investigation Results .......................................................................................................43 11.2.6 Complaints Review..........................................................................................................44 11.2.7 Recall Notification............................................................................................................44

11.3 Recalls ................................................................................................................................44 11.3.1 General............................................................................................................................44 11.3.2 Procedure Review ...........................................................................................................44 11.3.3 Notification.......................................................................................................................44 11.3.4 Distribution Records ........................................................................................................44 11.3.5 Identification ....................................................................................................................44 11.3.6 Reporting .........................................................................................................................45

12 Self Inspection (EC GMP Chapter 9) ........................................................................................45 12.1 Principle ..............................................................................................................................45

12.1.1 Self Inspection Programme.............................................................................................45 12.2 Self Inspection Audits .........................................................................................................45 12.3 Self Inspection Reports.......................................................................................................45

AIGA 023/05

1

1 Introduction

EC Directive 2001/83 defines a medicinal product as any substance or combination of substances:

• presented for treating or preventing disease in human beings • which may be administered to human beings with a view to making a medical diagnosis or to

restoring, correcting or modifying physiological functions in human This Directive requires that the manufacture of all medicinal products shall be controlled following the principles of Good Manufacturing Practice (GMP), detailed in the EC Good Manufacturing Practice Guide and defined in EC Directive 91/356EEC. The EC GMP Guide details the principles of the Quality Management System (QMS) that should be established by every manufacturer of medicinal products and is laid out in nine chapters, dealing with each aspect of the QMS. The purpose of the EC GMP Guide is to ensure that the manufacturing process is controlled so that the medicinal products are produced to the quality level specified in the appropriate Marketing Authorisation, where required, or the product specification.

The EC GMP Guide recognises the differences between the manufacture of traditional pharmaceutical products and medicinal gases and prescribes in Annex 6 of the Guide the specific elements of the QMS to be used to control the manufacture of medicinal gases. The requirements of Annex 6 have to be followed in addition to those of the main EC GMP Guide.

To assist the Medical Gas Industry in the interpretation of the overall requirements of the EC legislation with respect to GMP, this AIGA GMP Guide has been prepared. It has been structured so that it integrates the specific requirements of the Annex 6 of the EC GMP Guide into the parts of the main text that are relevant to medicinal gas manufacture to produce a single document to cover the requirements of the QMS system to control the manufacture of medicinal gases. Where the requirements of the EC Guide has no relevance to the manufacture of medicinal gases, these requirements have been omitted from the AIGA GMP Guide.

Hence, this AIGA GMP Guide may be used by all medicinal gas manufacturers to assist them in the preparation of a Quality Management System to ensure that all medicinal gases are manufactured to a specification that does not present any risks to the patient.

This AIGA GMP Guide mainly addresses the quality requirements for the manufacture and distribution of medicinal gases. These activities shall also comply with all of the other appropriate operational, safety and environmental requirements detailed within AIGA documents and any relevant national / international legislation and regulations.

2 Scope and Purpose

2.1 Scope

This AIGA GMP Code of Practice is intended for use by all manufacturers of medicinal gases and fillers of medicinal gas cylinders. It covers the manufacture and distribution of all medicinal gases on gas company premises and the filling of medicinal gas cylinders to meet the specifications set in the relevant Pharmacopoeial standards and, where required by the national authorities, in the relevant Marketing Authorisations. Where medicinal gases are covered by a Marketing Authorisation issued by a National Authority, the requirements detailed in this guide may be replaced with specific requirements detailed in those Marketing Authorisation.

This Guide does not cover manufacturing and handling of medicinal gases in hospitals, which will be subject to national legislation. However relevant parts of this guide may be used as a basis for such activities.

The contents of this Guide covers only the requirements set out in the main EC GMP Guide and Annex 6, covering the manufacture of medicinal gases. It currently does not cover the specific requirements detailed in Annex 15, Qualification and Validation, Annex 16, Certification by a Qualified Person and Batch Release, Annex 17, Parametric Release and Annex 18, Good Manufacturing Practice for Active Pharmaceutical Ingredients. Certain aspects of these requirements are covered in the AIGA GMP Guide where they have been referred to in the text of the main guide.

AIGA 023/05

2

This guide provides the minimum standards that are required to meet the requirements of the EC Directive 2001/83. Although the terminology of the AIGA Guide refers to activities that 'shall' be carried out, it may be appropriate to utilise alternative procedures provided that:

• It can be demonstrated by Risk Assessment that the alternative method provides at least the same level of protection to ensure that the quality of the final product is maintained

• Any Risk Assessment is formally documented • Approval is obtained from the national authorities to deviate from the requirements of the EC

GMP Guide •

Certain national authorities define some of the medical gases, that do not fall strictly under the definition of a medicinal product, as medical device gases. These gases, normally used in conjunction with medical devices, do not strictly fall under the control of the EC GMP Guide, but for the purposes of this document can be considered in the same way as for other medicinal gases. Within the text, any reference to the manufacture, filling or distribution of medicinal gases shall apply equally to any medical device gases.

2.2 Purpose

The purpose of this document is to provide manufacturers of medicinal gases and fillers of medicinal gas cylinders with a comprehensive guide for the development of a Quality Management System to control their relevant processes. It is intended to be used to assist the company in preparing a QMS to meet the GMP requirements, as well as the other requirements for management systems, such as ISO 9000 / 2000, and may also be used as a guide during pharmaceutical inspections by the national authorities.

3 Definitions

There following terms have the specific meanings detailed below when used in the context of the AIGA GMP Guide.

Shall / must Indicates a requirement that is mandatory that is either prescribed by the legislation or is considered to be the best operating practice by the medicinal gas industry.

Should / may Indicates a requirement which is preferred method of achieving a requirement but may be substituted by an alternative method provided that this method achieves the same requirement to at least the same standard.

Good Manufacturing Practice Good Manufacturing Practice is that part of Quality Assurance which ensures that medicinal gases are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the Marketing Authorisation or product specification.

Medicinal Gas A gas used for treating or preventing disease in human beings or administered to human beings with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions.

Medical Device Gas A gas used in conjunction with a medical device that does not comply with the definition of a medicinal gas.

Marketing Authorisation An authorisation issued by the national authority to permit a medicinal gas to be marketed within their territory, as described by Article 6 of EC Directive 2001/83EC. The Marketing Authorisation (MA) details include the

AIGA 023/05

3

specification of the medicinal gas, the method and sites of manufacture, the method of supply, including specification of the cylinder or container and the valve closure, clinical indication and contra-indications and precautions for use. Currently, not all national authorities require a Marketing Authorisation for all medicinal gases to allow them to be marketed within their territory.

Manufacturing Authorisation An authorisation issued by the national authority to permit the manufacture of specified medicinal gases on specific sites as described by Article 40 of EC Directive 2001/83EC. The Manufacturing Authorisation specifies the medicinal gases that may be manufactured and filled into cylinders on specific sites, the names of the responsible persons on each site and the name of the Qualified Person, where required by the national authority.

Qualified Person The Qualified Person (QP) is a nominated person responsible for the final certification of all medicinal gases prior to supply to the patient, as described by Article 48 of EC Directive 2001/83EC. The qualifications required by the Qualified Person are described in Article 49 of EC Directive 2001/83EC. Currently, not all national authorities require a Qualified Person to release all medicinal gases for patient use.

Test Unless otherwise stated, the term test refers to either the sampling and analysis of the medicinal gas at various stages in the process of manufacture or cylinder filling or to the process of validating that the specification of the finished conforms with the requirements of the Marketing Authorisation or product specification.

Pharmacopoeia Monograph The Pharmacopoeia Monograph refers to the specification and test methods for specific medicinal gases prepared and issued by the European Pharmacopoeia.

Production Site A Production Site refers to any site, covered by a Manufacturing Authorisation, where a bulk medicinal gas is produced.

Manufacturing Site A Manufacturing Site refers to any site, covered by a Manufacturing Authorisation, where a medicinal gas cylinders are filled.

Bulk Medicinal Gas A bulk medicinal gas is a gas supplied directly to the end user or to a medicinal gas cylinder filling site, where it has to be further processed before it can be used by the patient.

4 Quality Management (EC GMP Chapter 1)

4.1 Principle

Any manufacturer of medicinal gases or filler of medicinal gas cylinders, holding an appropriate Manufacturing Authorisation, shall ensure that the medicinal gases they produce are:

AIGA 023/05

4

• fit for their intended use by the patient, • compliant with the requirements of their Marketing Authorisation, where required, • safe, of an appropriate quality and efficacious so that they do not place patients at risk

The attainment of this quality objective is the responsibility of the senior management and requires the participation and commitment of staff in many different departments, at all levels within the company, and by the company’s suppliers and distributors.

To achieve the quality objective reliably there shall be a comprehensively designed and correctly implemented Quality Assurance system, incorporating the principles of Good Manufacturing Practice and Quality Control. The Quality Assurance system shall be fully documented and have its effectiveness monitored on a regular basis.

All parts of the Quality Assurance system shall be adequately resourced with competent personnel, and suitable and sufficient premises, equipment and facilities. In addition, where required by the national authority, all medicinal gases shall be formally released for patient use by the Qualified Person.

EC Directive 2001/83 specifies the specific legal responsibilities for both the holder of the Manufacturing Authorisation and the Qualified Person.

The basic concepts of Quality Assurance, Good Manufacturing Practice and Quality Control are inter-related. They are described here in order to emphasise their relationships and their fundamental importance to the production and control of the manufacture of medicinal gases and the filling of medicinal gas cylinders.

4.2 Quality Assurance (QA)

Quality Assurance is a wide ranging concept which covers all matters which individually or collectively influences the quality of the medicinal gas. It is the sum total of the organised arrangements made with the object of ensuring that medicinal gases are of the quality required for their intended use. Quality Assurance therefore incorporates the principles of Good Manufacturing Practice as well as other factors outside the scope of this AIGA GMP Guide.

The system of Quality Assurance appropriate for the production of medicinal gases and the filling of medicinal gas cylinders shall ensure that:

• The equipment and procedures used for the production of medicinal gases and the filling of medicinal gas cylinders are designed and developed in a way that takes account of the requirements of Good Manufacturing Practice.

• Production and Quality Control operations are clearly specified and the principles of Good Manufacturing Practice and Good Laboratory Practice adopted.

• Managerial responsibilities are clearly specified. • All necessary controls on starting and packaging materials, intermediate products, and any

other in-process controls and validations are carried out. • The bulk medicinal gases and the filled medicinal gas cylinders are correctly processed and

checked, according to the defined Standard Operating Procedures and individual Work Instructions.

• Where the national regulations specify, medicinal gases are not sold or supplied before a Qualified Person has certified that each production batch has been produced and controlled in accordance with the specifications of the Marketing Authorisation and any other regulations relevant to the production, quality control and release of medicinal gases.

• Satisfactory arrangements exist to ensure, as far as possible, that the medicinal gases are stored, distributed and subsequently handled so that quality of the gas and the condition of the containers are maintained throughout their shelf life.

• There is a procedure for self-inspection and quality audit which regularly appraises the effectiveness and applicability of the Quality Assurance systems.

AIGA 023/05

5

4.3 Good Manufacturing Practice (GMP) for Medicinal Gases

Good Manufacturing Practice is that part of Quality Assurance which ensures that medicinal gases are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the Marketing Authorisation or product specification.

Good Manufacturing Practice is concerned with the Quality Control of the production, filling and distribution of medicinal gases.

The basic requirements of Good Manufacturing Practice are that:

• All manufacturing processes are clearly defined, systematically reviewed in the light of experience and shown to be capable of consistently manufacturing or filling medicinal gases to the required quality so that they comply with their specifications.

• Critical steps of the manufacturing processes and any significant changes to the process are validated

• All necessary facilities for Good Manufacturing Practice are provided including: • appropriately qualified and trained personnel • adequate premises and space to carry out all operations • suitable equipment and services • correct materials, containers and labels • approved Standard Operating Procedures and Work Instructions • suitable finished product storage and methods of distribution.

• Work Instructions and Standard Operating Procedures are written in an instructional form in clear and unambiguous language, applicable to the facilities provided.

• Operators are trained to carry out procedures correctly and their competency assessed against a documented programme.

• Records are made, manually or electronically during manufacture of the medicinal gases and the filling of medicinal gas cylinders. These records shall demonstrate that all the required steps, defined by the Standard Operating Procedures and Work Instructions, have been taken and that the quantity and quality of the medicinal gas is as expected. Any significant deviations from these requirements are fully recorded and investigated.

• Records of the manufacture and distribution of the medicinal gases provide the complete history of the batch are retained in a comprehensible and accessible form. These records shall be comprehensive enough to allow the batch to be traced in the event of a product recall.

• The method of storage and distribution of the medicinal gases minimises any risk to their quality.

• A system is available to recall any batch of product, from sale or supply. • Complaints about marketed products are examined, causes of quality defects investigated and

appropriate measures taken in respect of the defective products to prevent reoccurrence.

4.4 Quality Control (QC)

Quality Control is that part of Good Manufacturing Practice which is concerned with sampling, testing and specifications of medicinal gases. It is also concerned with the organisation, documentation and release procedures which ensure that the necessary and relevant tests are actually carried out and that medicinal gases are not released for patient use until their quality has been judged satisfactory.

The basic requirements of Quality Control are that:

• Adequate facilities, trained personnel and approved procedures are available for the sampling, inspecting and testing of starting materials, packaging materials, bulk medicinal gases and filled medicinal gas cylinders for Good Manufacturing Practice purposes.

AIGA 023/05

6

• Samples of starting and packaging materials, bulk products and filled cylinders are taken by personnel and the test methods approved by the Quality Controller.

• Test methods are validated. • Records are made, manually or electronically by recording instruments, to demonstrate that all

the required sampling, inspecting and testing procedures are carried out. Any deviations are fully recorded and investigated.

• The bulk medicinal gases and the filled medicinal gas cylinders comply with the qualitative and quantitative specification of the finished product and are correctly labelled.

• Records are made of the results of inspection and testing of starting materials, bulk medicinal gases and filled medicinal gas cylinders. These records shall be formally assessed against the specification by the relevant Quality Controller. Product assessment shall include a review of the relevant medicinal gas production and filling documentation and a review of any significant deviations from the specified procedures.

• Each batch of bulk medicinal gas or medicinal gas cylinders is released for patient use and certified by the Qualified Person, where required by the national authorities, prior to supply, confirming that it is in accordance with the requirements of the Marketing Authorisation and the product specification.

5 Personnel (EC GMP Chapter 2)

5.1 Principle

The establishment and maintenance of a satisfactory system of Quality Assurance (QA) for the correct production of medicinal gases and filling of medicinal gas cylinders relies upon people. For this reason there must be sufficient qualified and trained personnel to carry out all the tasks involved in the production of medicinal gases and the filling of medicinal gas cylinders. Records shall be maintained to demonstrate that individuals clearly understand their specific responsibilities.

All personnel involved in the manufacture and assembly of medicinal gases shall receive initial and continuing training relevant to their needs and responsibilities. Specifically they shall be trained and assessed in their awareness of Good Manufacturing Practice (GMP) and be made aware of the critically important aspects of their roles and the potential hazards for patients from the medicinal gases should they not follow the specified procedures.

5.2 General

5.2.1 Personnel requirements

The manufacturer of medicinal gases and the filler of medicinal gas cylinders shall have an adequate number of personnel with the necessary qualifications and practical experience available to carry out all operations. The responsibilities placed on any one individual shall not be so extensive as to present any risk to quality of the gas supplied for patient use.

5.2.2 Organisation Chart

The manufacturer of medicinal gases and the filler of medicinal gas cylinders shall have an organisation chart detailing the reporting structures throughout the organisation. All personnel in responsible positions shall have their specific duties recorded in their written job descriptions and adequate authority to carry out their responsibilities. These duties may be delegated to designated deputies of a satisfactory qualification level. There shall be no gaps or unexplained overlaps in the responsibilities of those personnel concerned with the application and control of GMP.

AIGA 023/05

7

5.3 Key Personnel

5.3.1 Responsibilities

The holder of a Manufacturing Authorisation shall have available on every manufacturing site:

• a nominated person responsible for Production • a nominated person responsible for Quality Control.

Normally these key posts should be occupied by full time personnel. Under certain circumstances, the persons named on the Manufacturing Authorisation may not be resident on the site but shall still retain the overall responsibilities for production and/or quality control.

The Heads of Production and Quality Control must be independent from each other. In large organisations, it may be necessary for the nominated Head of Production or Quality Control to delegate some of their responsibilities to another suitably qualified person.

Where required by the national authority, each site shall also have a person nominated as the Qualified Person, who shall be responsible for the final release of all bulk medicinal gases or filled medicinal cylinders prior to the supply to the patient. The duties of the Qualified Person are fully described in EC Directive 2001/83 EC.

5.3.2 Independence

The level of independence of Quality Control to Production is considered fundamental to the satisfactory operation of Quality Control. The Quality Controller shall have the authority to prevent any finished medicinal gases that do not meet the specification from being supplied for patient use.

5.3.3 Person Responsible for Production

The Person Responsible for Production is generally responsible for:

• ensuring that the manufacture of medicinal gases and the filling of medicinal gas cylinders follows the authorised procedures detailed on the Marketing Authorisation, where required, in order to obtain the specified quality.

• checking that the maintenance of the equipment and premises under his control are carried out correctly

• ensuring that the appropriate process validations are completed • ensuring that the required initial and continuing training of his department personnel is carried

out and adapted according to the identified need • ensuring that any agreed self inspection programme is completed and that the appropriate

actions are taken to correct any identified non-compliances.

5.3.4 Person Responsible for Quality Control

The Head of the Quality Control Department is generally responsible for:

• approving or rejecting, as they see fit, starting materials, packaging materials, and intermediate bulk and finished product.

• evaluating batch records. • ensuring that all necessary testing is carried out. • approving specifications, sampling instructions, test methods and other QC procedures. • approving and monitoring any contract analysis. • checking the maintenance of their department, premises and equipment • ensuring that the appropriate quality control validations are completed.

AIGA 023/05

8

• ensuring that the required initial and continuing training of their department personnel is carried out and adapted according to need.

5.3.5 Joint Responsibilities

The persons responsible for Production and Quality Control generally have some shared or jointly exercised responsibilities relating to the quality of the medicinal gases.

These responsibilities may include:

• authorisation of written procedures and other documents, including amendments • procedure validation • training • designation and monitoring of storage and distribution conditions for materials and products • retention of records • monitoring of compliance with the requirements of GMP • control of any changes to procedures or equipment, including any relevant validations

5.3.6 The Qualified Person

Where required by the national authorities, the Qualified Person's responsibilities shall include:

• ensuring that each batch of bulk medicinal gas or filled medicinal gas cylinders has been produced and tested /checked in accordance with the relevant directives and the appropriate Marketing Authorisation.

• certifying in a register or equivalent document, as operations are carried out and before any release, that each production batch satisfies the provisions of the EC Directive 2001/83 EC.

• approve specifications, sampling instructions, test methods and any other Quality Control procedures

• verify that the appropriate validations are completed. • verify that the required initial and continuing training of his department personnel is carried out

and adapted according to the identified need. • approval and monitoring of suppliers and materials. • approval and monitoring of contract manufacturers • making the decision to recall potentially defective finished product and to assist, as necessary,

in the investigation procedure and any follow-up actions when informed of any product non-conformance

The person responsible for the Qualified Person duties must meet the qualification requirements laid down in EC Directive 2001/83 EC and shall be permanently and continuously at the disposal of the holder of the Manufacturing Authorisation to carry out these responsibilities.

The Qualified Person's responsibilities may be delegated to another certified Qualified Person with the appropriate experience.

The Qualified Person responsible for release of medicinal gases shall have a thorough knowledge of the production and control of medicinal gases.

5.4 Training

Manufacturers of medicinal gases and fillers of medicinal gas cylinders shall provide training for all the personnel whose duties take them into production areas or laboratories (including the technical, maintenance and cleaning personnel), and for other personnel whose activities could affect the quality of the product.

AIGA 023/05

9

Besides the basic training on the theory and practice of GMP relevant to the manufacture of medicinal gases, newly recruited personnel shall receive training appropriate to the duties assigned to them.

Continuing training shall also be given, and its practical effectiveness shall be periodically assessed.

Training programmes for all personnel shall be available, approved by either the Head of Production or the Head of Quality Control, as appropriate. Training records shall be retained.

5.4.1 Hazard Areas

Personnel working in areas where contamination is a hazard or areas where toxic materials are handled, shall be given specific training.

5.4.2 Visitors

Visitors or untrained personnel should not be taken into the Production and Quality Control areas. If this is unavoidable, they should be closely supervised and given the appropriate information in advance, particularly about personal hygiene and the prescribed protective clothing.

5.4.3 Quality Assurance Training

The concept of Quality Assurance and all the measures capable of improving its understanding and implementation shall be fully discussed as part of the overall training programme during training sessions.

5.5 Protective Clothing

For safety reasons every person entering the manufacturing areas shall wear protective garments appropriate to the operations to be carried out.

Personnel shall be instructed to use gloves when handling medicinal gas cylinder valves.

5.6 Personal Hygiene

Separate facilities shall be provided for personnel for eating, drinking or smoking remote from any production and quality control areas. These facilities should include storage for food and drink or any smoking materials. In general, any unhygienic practice within the manufacturing areas or in any other area where the product might be adversely affected, shall be forbidden.

6 Premises and Equipment (EC GMP Chapter 3)

6.1 Principle

Premises and equipment for manufacture of medicinal gases and the filling of medicinal cylinders must be located, designed, constructed, adapted and maintained to suit all of the relevant operations. The layout and design of the premises must aim to minimise the risk of errors and permit effective cleaning and maintenance of the equipment and not have any adverse effect on the quality of products.

The manufacture of medicinal gases and the filling of medicinal gas cylinders is generally carried out in closed pipework, containers and tanks. Consequently, environmental contamination of the product is minimal, provided that the equipment is suitably commissioned and maintained in an operational condition. However there could be a risk of cross-contamination with other gases if the pipework allows for interconnections between different gases without any suitable backflow protection and the appropriate, validated procedures are not followed correctly.

AIGA 023/05

10

6.2 Premises

Premises shall provide sufficient space for manufacturing, filling, testing, inspection and storage of medicinal gases to avoid the risk of mix-up. Premises shall be kept clean and tidy to encourage orderly working and have adequate space to permit the storage of cylinders to be correctly laid out with adequate segregation.

6.2.1 Maintenance

Premises and equipment shall be carefully regularly cleaned and maintained to a documented preventative maintenance programme. The repair and maintenance operations shall ensure that they do not present any hazard to the quality of the medicinal gas, and be carried out according to detailed written procedures.

6.2.2 Unauthorised Entry

Steps shall be taken to prevent the entry of unauthorised people to production, cylinder filling, storage and quality control areas, which must not be used as a right of way by personnel who do not work in them.

6.3 Manufacturing Areas - Production

6.3.1 Location

Except where special precautions are taken, production equipment shall be located away from any incompatible activities such as those that generate any chemical or biological emissions

6.3.2 Storage Areas

Where starting materials are stored prior to use, they shall be kept in an environment where contamination is avoided and deterioration is controlled.

6.4 Manufacturing Areas - Cylinder Filling

6.4.1 Layout

Premises used for the filling of medicinal gas cylinders should preferably be laid out in such a manner as to allow a flow through the area, with each cylinder filling step taking place in an areas connected in a logical order corresponding to the sequence of the cylinder filling operations. Cylinder filling areas shall be of a sufficient size and have an orderly layout, providing separately marked areas for different gases and, where applicable, different cylinder sizes.

A typical plant layout is shown in Figure 1, Typical Medicinal Cylinder Filling Facility Layout

AIGA 023/05

11

Management Offices

Plant Maintenance Area Analysis / Laboratory Area

Medicinal Nitrous Oxide Cylinder Filling

Area

Medicinal Oxygen

Cylinder Filling Area

Medicinal Synthetic Air

Cylinder Filling Area

N2 Tank

O2 Tank

N2O Tank

Starting Material Storage Area

Delivery Vehicle Loading / Unloading Area

Out In

Storage Area for Returned Empty

Cylinders

Storage Area for Empty Cylinders

Suitable for Filling

Quarantine Area for Cylinders

Awaiting Release

Storage Area for Full Released

Cylinder Awaiting Delivery

Storage Area for Non-conforming

Cylinders

Storage Area for Cylinders

Requiring Test Shop Attention

Medicinal Cylinder Filling Area

Medicinal Cylinder Storage Area

Fig 1 Layout of a Typical Medicinal Cylinder Filling Plant

AIGA 023/05

12

6.4.2 Segregated Areas

Medicinal gases should preferably be filled in a separate area from non-medicinal gases and there should be no exchange of cylinders between these areas. In exceptional cases, the principal of campaign filling in the same area can be accepted provided that specific precautions are taken and necessary validation is done to ensure that there is no confusion between medicinal and non-medicinal gas cylinders.

6.4.3 Inspection and Testing Areas

Facilities for the inspection, testing and maintenance of medicinal gases cylinders shall be specifically designed and laid out so as to avoid mix-ups or contamination of the cylinders.

6.4.4 Lighting

Cylinder filling areas must be well lit, particularly where visual on-line controls are carried out.

6.4.5 In-process Controls

In-process controls may be carried out within the production and filling areas provided they do not present any risks to the production of medicinal gases and the filling of medicinal gas cylinders.

6.5 Storage Areas - Cylinder Filling

Storage areas for medicinal gas cylinders shall be of a sufficient size and capacity to allow for orderly storage and to permit clearly identifiable segregation areas of the different gases filled on site and to differentiate the status of the stored cylinders.

The method used to achieve the various levels of segregation will depend on the nature, extent and complexity of the overall operation. Marked out floor areas, partitions, barriers, labels, signs or other appropriate means could be used to identify storage areas.

6.5.1 Layout

Cylinder storage areas shall be clearly identified and provide suitable segregation to allow distinction between the various stages reached by given cylinders, including:

• empty cylinder storage area where cylinders returned from customers can be stored prior to cylinder sorting

• empty cylinder sorting area where cylinders can be segregated into those suitable for refilling and those requiring either statutory testing or rectification prior to refilling

• empty cylinder storage area for cylinders suitable for refilling • quarantine area for filled cylinders awaiting quality control and formal release • full cylinder storage area for released cylinders • rejected non-conforming cylinders

6.5.2 Storage Area Protection

All gas cylinders shall be stored in nominated storage areas, preferably under cover and not subjected to extremes of weather conditions and ambient temperature. Storage areas must be kept clean, dry, well ventilated and free of combustible materials to ensure that cylinders remain clean up to the time of use.

AIGA 023/05

13

6.5.3 Stock Rotation

In order to permit batch segregation, medicinal gas cylinder shall be stored in an orderly fashion with adequate segregation of different gases and of full/empty cylinders. The storage arrangements must permit suitable rotation of stock to ensure that cylinders are used for supply to customers on a first in / first out basis.

6.5.4 Reject Cylinder Storage

Segregated labelled areas shall be provided for the storage of rejected, recalled or returned medicinal cylinders

6.5.5 Label Storage

Cylinder labels and package inserts (Patient Information Leaflets) are considered critical to the conformity of the medicinal gas product and special attention shall be paid to the safe and secure storage of these materials.

6.5.6 Storage Protection

Gas cylinders shall be suitably protected from adverse weather conditions during storage and transportation. Specific storage and transportation arrangements shall be used for gas mixtures where phase separation may occur with low ambient temperatures to ensure that the medicinal gas mixture is correctly mixed when used by the patient.

6.6 Quality Control Areas

The layout of the medicinal gas Quality Control areas shall have sufficient space for cylinder storage to avoid mix-ups or cross-contamination of sample cylinders. There shall be adequate suitable storage space for all medicinal gas sample cylinders and for the associated records.

6.6.1 Environmentally Controlled Areas

Laboratories for the testing of medicinal gases are only required where the analytical equipment needs to be maintained in a controlled environment.

6.6.2 Area Segregation

Finished product analysis areas should preferably be separated from production areas, unless the analysis equipment is installed at the medicinal cylinder filling point.

6.7 Ancillary Areas

6.7.1 Rest Areas

Rest and refreshment rooms shall be separate from production, cylinder filling, quality control and storage areas.

6.7.2 Toilet Areas

Washing and toilet areas, as well as facilities for changing clothes shall be easily accessible and designed for the appropriate number of users. These toilet facilities shall not have direct access with production, cylinder filling, quality control or storage areas.

AIGA 023/05

14

6.7.3 Maintenance Areas

As far as practicably possible, maintenance workshops should be separate from production and cylinder filling areas. Whenever parts and tools are stored in the production area, they should be kept in rooms or lockers reserved for that use.

6.8 Equipment

All equipment for manufacture, cylinder filling and analysis of medicinal gases shall be designed, qualified, calibrated and maintained to suit its intended purpose.

6.8.1 Maintenance and Cleaning

Repair and maintenance operations shall not adversely affect the quality of medicinal gases produced or filled into cylinders.

The design of manufacturing and cylinder filling equipment should permit easy and effective cleaning and evacuation to remove any internal contamination. Where the pipework or equipment requires specific cleaning, the system shall be designed so that any residual cleaning material can be easily removed prior to use. Detailed written procedures must be available to cover the appropriate methods of purging and cleaning all equipment.

These systems shall also be designed so as to not release any particulate matter into the finished product.

6.8.2 Material Selection

Manufacturing and cylinder filling equipment shall not present any hazard to the finished products. The parts of the equipment that come into contact with the product must not be reactive, additive or absorptive to such an extent that it will affect the quality of the product and thus present a hazard.

This specifically includes halogenated materials that could produce toxic gases if they should ignite, such as under adiabatic compression conditions.

6.8.3 Calibration

Critical instruments used for measuring, weighing, recording and controlling equipment shall have specific calibration periods using appropriate validated methods. All critical instruments must be calibrated and checked at the prescribed intervals. Detailed records of all of the calibration tests, including the 'as found' and the 'post calibration' values shall be maintained.

6.8.4 Labelling

Fixed pipework shall be clearly labelled as appropriate to indicate the contents of the pipework and the direction of the flow of the gas.

6.8.5 Defective Equipment

Defective equipment shall be clearly labelled as defective and, if possible, be removed as soon as possible from the manufacturing, production or laboratory areas.

AIGA 023/05

15

6.9 Equipment - Bulk Production

6.9.1 Plant Segregation

It is acceptable to manufacture non-medicinal gases and medicinal gases concurrently, such as in an air separation unit, provided that the quality of the non-medicinal gas is at least equal to the quality of the medicinal gas.

6.9.2 Air Filtration

In an air separation unit, where atmospheric air is used as a raw material, it shall be filtered at the inlet point to restrict the intake of particulate matter into the plant.

6.9.3 Controlled Conditions

Where the manufacturing plant has to operate at specific temperatures or pressures, the pipework shall be designed and tested to ensure that the critical plant control conditions can be maintained.

6.9.4 Equipment - Medicinal Cylinder Filling

6.9.5 Cylinder Filling Manifolds

The medicinal gas cylinder filling manifolds shall be dedicated to the filling of either a single medicinal gas or to a given mixture of medicinal gases to different concentrations.

The manifolds shall be equipped with fill connections that correspond only to the valve for that particular gas or mixture of gases so that the correct containers can be attached to the manifold without the use of an adapter. (The use of specific cylinder and container valve connections may be subject to international or national standards). It is necessary to ensure that the correct gas is put into the correct container.

Where the same medicinal gas cylinder valve is used for more than one medicinal gas, additional precautions shall be taken to ensure that the correct gas is filled into the correct cylinder.

The name of the gas or gas mixture being filled shall be displayed on each medicinal gas cylinder filling manifold.

6.9.6 Medicinal Cylinders

Cylinders in medicinal gas service shall be dedicated to that service and have the appropriate technical characteristics, according to international / national regulations. Cylinders shall be labelled and painted correctly, according to the national standards and to comply with the relevant Marketing Authorisation, where applicable.

6.9.7 Shared Filling Systems

Filling of medicinal gas cylinders shall be avoided in non-medicinal gas cylinders filling areas and not filled with equipment used for filling medicinal gas cylinders. In exceptional circumstances, where it is impracticable to have a dedicated medicinal gas cylinder filling facility, and where the national regulations permit, the principle of campaign filling may be used to allow medicinal gas cylinders to be filled on non-medicinal gas cylinder filling equipment. In these circumstances, the area shall be dedicated to medicinal gas cylinder filling during the campaign and appropriate tests and procedures carried out to ensure that the product is not contaminated with non-medicinal gas and the cylinders filled comply with the relevant specifications. GMP standards shall be maintained during the campaign filling process.

AIGA 023/05

16

Ideally, filling lines used to supply medicinal gas filling areas should be dedicated to that service. However, where it is necessary to have a shared facility serving both products, there shall be a validated method of backflow prevention in any line supplying the filling area for non-medicinal gases to prevent contamination of the medicinal gas from the possible impurities that may be returned in the non-medicinal gas cylinders.

6.9.8 Pipeline Interconnections

Except for validated automated filling processes there shall be no direct interconnections between pipelines carrying different gases other than for medical gas mixture filling systems.

6.9.9 Non-automated Filling Systems

Where an automated filling process is not available for the filling of medicinal gas mixtures, there shall be a documented procedure to demonstrate that the mixtures have been filled correctly and consistently and that there has been no backflow from any other cylinder filling process.

6.10 Equipment - Bulk Storage and Transport

6.10.1 Storage Tanks

Storage tanks and mobile delivery tankers shall be dedicated to one gas. The quality of the gas stored in the storage tank or mobile delivery tanker must be well defined and shall be at least equal to the medicinal gas quality standard. The storage tank and delivery tanker shall have product specific couplings for the transfer of product to another storage tank or tanker to prevent the wrong gas from being transferred into the tank.

6.10.2 Common Storage Tanks

Bulk medicinal gases from the manufacturing plant may be stored in the same batch or bulk storage tank as non-medicinal gases, provided that, if permitted by local regulations, the quality of the non-medicinal gas is at least equal to the quality of the medicinal gases.

6.10.3 Common Delivery Vehicles

If permitted by local regulations, cryogenic liquefied medicinal gases may be transported in the same tankers as non-medicinal gases. This may only be permitted provided that the quality of the non-medicinal gas is at least equal to the quality of the medicinal gas. There must also be a validated backflow protection device fitted to prevent backfeeding of non-medicinal product from the customer's storage tank into the tanker when product is being transferred.

Where tankers are used for delivering liquefiable gases, where a two hose filling system is used to balance the pressure between the tanker and the storage tank, then either:

The deliveries of medicinal gases shall be made before any non-medicinal deliveries are made, to ensure that there is no cross contamination between medicinal and non-medicinal customer storage tanks

The assay of the gas being delivered to a medicinal customer is monitored prior to the tanker off loading any product. The testing procedure needs to consider the likely contaminants that may be present to confirm that there has been no degradation of the product.

With this type of delivery system, there needs to be a procedure in place to assess the likely contaminants from the non-medicinal customers and procedures put in place to ensure that the tanker has not been contaminated with any likely contaminants prior to the tanker being refilled for medical deliveries.

AIGA 023/05

17

7 Documentation (EC GMP Chapter 4)

7.1 Principles

Good documentation is an essential part of all Quality Assurance systems used for the production of bulk medicinal gases and the filling of medicinal gas cylinders. Clearly written documentation prevents errors from spoken communication and permits the tracing of batch history. Specifications, Standard Operating Procedures, Work Instructions, and records must be controlled and available to all of the relevant personnel either in written or electronic format.

All written documents shall be legible and free from errors.

7.2 General

7.2.1 Starting Materials

All starting materials involved in both the production of bulk medicinal gases and the filling of medicinal gas cylinders shall be specified to the appropriate standards, as detailed in the relevant Marketing Authorisation or any other relevant legislation. As well as any bulk starting materials, the specifications shall include, as required, the details of cylinders, cryogenic containers, valves, labels and leaflets used in the supply of the medicinal gases.

These specifications shall serve as the basis for all quality evaluations in the Quality Control system used to control any starting materials.

7.2.2 Work Instructions

All Work Instructions shall detail the specific steps in the production process and the medicinal cylinder filling procedures.

7.2.3 Standard Operating Procedures

Standard Operating Procedures (SOPs) shall specify all of the starting materials to be used and detail the specific requirements for any equipment cleaning operations, specific personal protective equipment requirements, sampling and testing frequencies and all equipment operation process requirements.

7.2.4 Batch Records

Batch records shall provide a history of each batch of bulk medicinal gas produced or batch of medicinal gas cylinders filled. These batch records should include all details pertinent to the quality of the final product.

Batch records shall be designed such that all significant recordable activities involved in either the manufacture of medicinal gases or the filling of medicinal gas cylinders permit the traceability of each defined batch. All batch records shall be dated and signed by the Quality Controller.

7.2.5 Document Control

All documentation shall be designed, prepared, reviewed, dated and distributed and controlled to comply with the specific requirements of the Manufacturer’s Licence, Marketing Authorisations and any other relevant legislation.

All Standard Operating Procedures, Work Instructions and specifications shall be controlled to ensure that only the current version is readily available for reference.

AIGA 023/05

18

The document control procedure shall ensure that only the current version of any document is available and all superseded documents are destroyed.

Photocopied documents shall be clear and legible. The copying of any working document from a master document shall not allow any error to be introduced through the reproduction process.

7.2.6 Document Approval

All documents involved in the production of medicinal gases and the filling of medicinal gas cylinders shall be approved, signed and dated by the Quality Controller.

7.2.7 Document Design

Documents must be designed so that their nature and purpose is clearly defined and that they have a specific title and defined content. They should be laid out in an orderly fashion to make the audit of the information easy to check.

7.2.8 Document Review

Documents shall be regularly reviewed and kept up-to-date to reflect the current Work Instructions, Standard Operating Procedures and specifications (where detailed in the Mark